BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15194785)

  • 1. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
    Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
    J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.
    Mulky A; Kappes JC
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3762-9. PubMed ID: 16127051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
    Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC
    J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
    Mulky A; Vu BC; Conway JA; Hughes SH; Kappes JC
    J Mol Biol; 2007 Feb; 365(5):1368-78. PubMed ID: 17141805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
    Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
    FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
    Amacker M; Hübscher U
    J Mol Biol; 1998 May; 278(4):757-65. PubMed ID: 9614940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME; Parniak MA
    J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
    Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
    Sluis-Cremer N; Arion D; Abram ME; Parniak MA
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HIV type 1 reverse transcriptase expression in a human cell line.
    Ansari-Lari MA; Gibbs RA
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1117-24. PubMed ID: 7530025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase.
    Tachedjian G; Radzio J; Sluis-Cremer N
    Proteins; 2005 Jul; 60(1):5-13. PubMed ID: 15852304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X; Liu H; Xiao H; Conway JA; Hunter E; Kappes JC
    EMBO J; 1997 Aug; 16(16):5113-22. PubMed ID: 9305652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic residue 438 within the protease-sensitive subdomain of HIV-1 reverse transcriptase is critical for heterodimer processing in viral particles.
    Navarro JM; Damier L; Boretto J; Priet S; Canard B; Quérat G; Sire J
    Virology; 2001 Nov; 290(2):300-8. PubMed ID: 11883194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme.
    Tasara T; Amacker M; Hübscher U
    Biochemistry; 1999 Feb; 38(5):1633-42. PubMed ID: 9931031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The β1'-β2' Motif of the RNase H Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Responsible for Conferring Open Conformation to the p66 Subunit by Displacing the Connection Domain from the Polymerase Cleft.
    Pandey AK; Dixit U; Kholodovych V; Comollo TW; Pandey VN
    Biochemistry; 2017 Jul; 56(27):3434-3442. PubMed ID: 28627879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression and purification of untagged and histidine-tagged HIV-1 reverse transcriptase.
    Hou EW; Prasad R; Beard WA; Wilson SH
    Protein Expr Purif; 2004 Mar; 34(1):75-86. PubMed ID: 14766302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer.
    Harris D; Lee R; Misra HS; Pandey PK; Pandey VN
    Biochemistry; 1998 Apr; 37(17):5903-8. PubMed ID: 9558323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta7-beta8 loop of the p51 subunit in the heterodimeric (p66/p51) human immunodeficiency virus type 1 reverse transcriptase is essential for the catalytic function of the p66 subunit.
    Pandey PK; Kaushik N; Talele TT; Yadav PN; Pandey VN
    Biochemistry; 2001 Aug; 40(32):9505-12. PubMed ID: 11583149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
    Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
    Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
    Olivares I; Mulky A; Boross PI; Tözsér J; Kappes JC; López-Galíndez C; Menéndez-Arias L
    J Mol Biol; 2007 Sep; 372(2):369-81. PubMed ID: 17651754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.